The cholesterol hypothesis implies that reducing the intake of saturated fatty acids and cholesterol and increasing that of polyunsaturated fatty acid are eŠective in lowering serum total cholesterol (TC), and thereby reducing the incidence of coronary heart disease (CHD). However, these dietary recommendations are essentially ineŠective in reducing TC in the long run, but rather increase mortalitiy rates from CHD and all causes. The reported``apparent relative risk of high TC in CHD mortality'' (the ratio of mortality at the highest/lowest TC levels) varied several-fold among populations studied. The incidence of familial hypercholesterolemia (FH) in a population was proposed to be a critical factor in the observed variability, which could be accounted for by assuming that 1) the high CHD mortality rate in high-TC groups is mainly a re‰ection of the incidence and severity of FH, and 2) high TC is not a causative factor of CHD in non-FH cases. This interpretation is supported by recent observations that high TC is not positively associated with high CHD mortality rates among general populations more than 40-50 years of age. More importantly, higher TC values are associated with lower cancer and all-cause mortality rates among these populations, in which relative proportions of FH are likely to be low (circa 0.2％). Although the eŠectiveness of statins in preventing CHD has been accepted in Western countries, little beneˆt seems to resulf from eŠorts to limit dietary cholesterol intake or to TC values to less than approximately 260 mg/dl among the general population and the elderly. Instead, an unbalanced intake of v6 over v3 polyunsaturated fats favors the production of eicosanoids, the actions of which lead to the production of in‰ammatory and thrombotic lipid mediators and altered cellular signaling and gene expression, which are major risk factors for CHD, cancers, and shorter longevity. Based on the data reviewed here, it is urgent to change the direction of current cholesterol-related medication for the prevention of CHD, cancer, and all-cause mortality.
はじめに
Dietary recommendations based on the cholesterol hypothesis were ineŠective but rather were risky for a subgroup with hypertension and ECG anomaly. Dietary advice was revealed to be a risk factor with the highest hazard ratio. TC and LDL-cholesterol were highly positively associated with the complication with heart disease. The subjects included familial hypercholesterolemia at 19-fold greater incidence than in general population (0.2％). No positive association was observed between TC and CHD. Instead, all-cause mortality and cancer mortality were lower when TC level was higher in men. Similar observations have been revealed by follow-up studies performed in other cities (Fukui, Hisayama, Toda and Ibaraki).
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（Brown and Goldstein）により見出された LDL 受 Comparison of Framingham general population and the subjects in MRFIT study, which were selected from top 10-15％ of TC level. The original article gave relative risk for each cause of death. Here the relative risk multiplied by the mortality for each cause is shown to visualize the contribution of each cause to all-cause mortality. It should be noted that this subject population included FH at 12-fold greater incidence than in general population (0.2％). Decreasing TC was positively associated with increasing mortalities from heart disease and all causes. In order to eŠectively increase EPA in tissue phospholipids, intake of competitive LA must be reduced. 
